Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity.

Source:http://linkedlifedata.com/resource/pubmed/id/15339925

J. Biol. Chem. 2004 Nov 19 279 47 49430-8

Download in:

View as

General Info

PMID
15339925